Article Cited by others

REVIEW ARTICLE

Management of diabetes in the elderly with canagliflozin: A newer hypoglycemic drug on the horizon

Sehgal Vishal, Bajwa Sukhminder Jit Singh, Sehgal Rinku, Consalvo John A

Year : 2014| Volume: 5| Issue : 4 | Page no: 227-231

   This article has been cited by
 
1 Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitor: Comparing Trial Data and Real-World Use
Andrew McGovern,Michael Feher,Neil Munro,Simon de Lusignan
Diabetes Therapy. 2017; 8(2): 365
[Pubmed]  [Google Scholar] [DOI]
2 Treating Diabetes in Patients with Heart Failure: Moving from Risk to Benefit
Ersilia M. DeFilippis,Michael M. Givertz
Current Heart Failure Reports. 2016;
[Pubmed]  [Google Scholar] [DOI]
3 Características diferenciales de la diabetes mellitus tipo 2 en el paciente anciano. Papel de los inhibidores de la dipeptidil peptidasa 4
Francesc Formiga,Ricardo Gómez-Huelgas,Leocadio Rodríguez Mañas
Revista Española de Geriatría y Gerontología. 2016; 51(1): 44
[Pubmed]  [Google Scholar] [DOI]
4 Special considerations for the treatment of chronic kidney disease in the elderly
Andrea Corsonello,Sergio Fusco,Silvia Bustacchini,Carlos Chiatti,Raffaella Moresi,Anna Rita Bonfigli,Giuseppina Di Stefano,Fabrizia Lattanzio
Expert Review of Clinical Pharmacology. 2016; : 1
[Pubmed]  [Google Scholar] [DOI]
5 Papel de los inhibidores SGLT2 en el paciente anciano con diabetes mellitus; debemos evitar la discriminación por razón de edad
Francesc Formiga,Leocadio Rodríguez-Mañas,Ricardo Gómez-Huelgas
Revista Española de Geriatría y Gerontología. 2016;
[Pubmed]  [Google Scholar] [DOI]
6 New Guidelines for Elderly Diabetic Patients
Jihyun Lee
The Journal of Korean Diabetes. 2015; 16(2): 89
[Pubmed]  [Google Scholar] [DOI]

 

Read this article